ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016 ACR/ARHP Annual Meeting
    • 2015 ACR/ARHP Annual Meeting
    • 2014 ACR/ARHP Annual Meeting
    • 2013 ACR/ARHP Annual Meeting
    • 2012 ACR/ARHP Annual Meeting
    • 2011 ACR/ARHP Annual Meeting
    • 2010 ACR/ARHP Annual Meeting
    • 2009 ACR/ARHP Annual Meeting
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1805

Perioperative Anti-rheumatic Medications Are Not Associated with 30-day Odds of Infection in Rheumatoid Arthritis Patients Undergoing Surgery: A Retrospective Cohort Study

Marianne Kerski1, Peter Boersma 2, Eric Miller 3, Ashley Brenner 4, Genevieve Melton 5 and Anna Shmagel 6, 1University of Minnesota Medical School, Minneapolis, MN, 2University of Minnesota School of Public Health, Minneapolis, 3University of Minnesota, Woodbury, MN, 4University of Minnesota Best Practices Integrated Informatics Core (BPIC), Minneapolis, MN, 5University of Minnesota Department of Surgery, Minneapolis, MN, 6University of Minnesota, Minneapolis, MN

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Biologics and DMARDs, Infection, Rheumatoid arthritis (RA), surgery

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Monday, November 11, 2019

Session Title: 4M090: Infection-Related Rheumatic Disease (1800–1805)

Session Type: ACR Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Perioperative management of anti-rheumatic drugs in rheumatoid arthritis (RA) patients undergoing surgery remains controversial. Previous studies produced conflicting results, and data on non-orthopedic surgeries in RA patients are limited. The objective of the current study was to measure the impact of perioperative anti-rheumatic medication management on the 30-day odds of infection among RA patients undergoing surgery.

Methods: We conducted a retrospective cohort study of seropositive RA patients who underwent musculoskeletal or major organ surgery within the Fairview Health System in Minnesota between January 1, 2010 and December 31, 2017. Each surgical event was identified through the electronic medical record and manually reviewed by two trained clinicians for demographic variables, perioperative medication management, and outcomes. Surgeries were classified into three groups according to anti-rheumatic medication use during surgery: 1. neither DMARD nor biologic (either not prescribed or held for a pre-specified period of time, based on each medication’s dosing schedule and mode of action); 2. DMARD with no biologic; 3. biologic with or without DMARD. The perioperative use of corticosteroids and antibiotics was also recorded. The primary outcome, post-operative infection, included surgical site infections, urinary tract infections, pneumonia, and blood stream infections occurring within 30 days of surgery as defined by CDC criteria. ANOVA, Chi-square tests and logistic regression were used for analyses.

Results: 154 seropositive RA patients underwent 244 surgeries (165 musculoskeletal and 79 major organ). Patients were predominantly female (78%), white (94%), overweight or obese (73%) with a mean age of 62 years, and a mean Charlson comorbidity index of 2.3.  Of the 244 surgeries, 116 (47.8%) were performed on no anti-rheumatic medications, 95 (39.1%) on a DMARD with no biologic, and 32 (13.2%) on a biologic with or without a DMARD. The groups were well-balanced on age, sex, race, baseline BMI, Charlson comorbidity index, surgery type, perioperative steroid use, antibiotic use and expected duration of surgery (p ≥ 0.1 for all comparisons). In total, 28 surgeries (11.5%) among 23 patients were complicated by a post-operative infection within 30 days: 14 (12%) in the no-medication group, 10 (11%) in the DMARD group, and 4 (13%) in the biologic group (p = 0.9). Of the other examined predictors, higher Charlson comorbidity index and longer expected duration of surgery were associated with infection (p < 0.05).  After adjustment for these two predictors, overall and for musculoskeletal and major organ surgeries separately, perioperative use of anti-rheumatic drugs was not associated with increased odds of post-operative infection (table 1).

Conclusion: Perioperative use of anti-rheumatic medications was not associated with 30-day odds of post-operative infection in RA patients undergoing musculoskeletal or major organ surgery. Rather, higher Charlson comorbidity index and longer expected duration of surgery predicted postoperative infections in this RA population.


ACR Abstract 2019 Table 1


Disclosure: M. Kerski, None; P. Boersma, None; E. Miller, None; A. Brenner, None; G. Melton, None; A. Shmagel, None.

To cite this abstract in AMA style:

Kerski M, Boersma P, Miller E, Brenner A, Melton G, Shmagel A. Perioperative Anti-rheumatic Medications Are Not Associated with 30-day Odds of Infection in Rheumatoid Arthritis Patients Undergoing Surgery: A Retrospective Cohort Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/perioperative-anti-rheumatic-medications-are-not-associated-with-30-day-odds-of-infection-in-rheumatoid-arthritis-patients-undergoing-surgery-a-retrospective-cohort-study/. Accessed February 6, 2020.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/perioperative-anti-rheumatic-medications-are-not-associated-with-30-day-odds-of-infection-in-rheumatoid-arthritis-patients-undergoing-surgery-a-retrospective-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Annual Meeting in Atlanta, Georgia

© COPYRIGHT 2020 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.